Sam Brusco, Associate Editor05.22.24
Philips began a nationwide rollout in Spain of its ambulatory cardiac monitoring device in Spain, using its wearable ePatch with its artificial intelligence (AI)-driven Cardiologs analytics platform.
14 Spanish healthcare providers now use the company's ePatch extended wear Holter monitors to spot arrhythmias like atrial fibrillation (AFib). Philips said the technology has been proven to spot arrhythmias missed by traditional Holter monitors. The company also said the solution can improve patient comfort, boost access to care, offer better clinical outcomes, and reduce overall costs.
In some Spanish hospitals, the benefits of ePatch are helping reduce waiting lists that accumulated during the COVID-19 pandemic. Philips said over 1,500 patients total are currently being monitored with ePatch devices in Spain.
Dr. Jorge Pagola, Neurologist Postdoctoral Researcher at University Hospital Vall d'Hebron, Barcelona, Spain said a key advantage of using ePatch and the AI analytics platform is in its user-friendly interface and high-quality, 14-day continuous recording capabilities.
"Applied as a chest patch in just a few minutes, it seamlessly integrates an analysis program, facilitating swift examination of recordings,” Dr. Pagola told the press. “Thanks to its AI-based analysis assistant, AF events can be classified for rapid review by our team. Patients experience enhanced comfort as they are free from cumbersome cables of the conventional Holter, allowing them to dress, shower, and carry out their daily activities without any hindrance."
ePatch is also being used in pilot projects at major hospitals in Madrid, Barcelona, Bilbao, Alicante, Madrid, Cadiz, and Navarra to show effectiveness in cardiology and neurology. These applications include monitoring for AFib after cardiac ablation or heart valve replacement, as well as studies of the link between magnesium insufficiency and AFib.
“This innovative new service allows clinical teams to conveniently monitor patients as they go about their everyday activities for extended periods of time, collecting the real-life data that helps reveal the patient’s true condition,” said Miquel Barras, Ambulatory Monitoring & Diagnostics Lead for Philips in Spain.
Philips acquired France-based Cardiologs in 2021.
14 Spanish healthcare providers now use the company's ePatch extended wear Holter monitors to spot arrhythmias like atrial fibrillation (AFib). Philips said the technology has been proven to spot arrhythmias missed by traditional Holter monitors. The company also said the solution can improve patient comfort, boost access to care, offer better clinical outcomes, and reduce overall costs.
In some Spanish hospitals, the benefits of ePatch are helping reduce waiting lists that accumulated during the COVID-19 pandemic. Philips said over 1,500 patients total are currently being monitored with ePatch devices in Spain.
Dr. Jorge Pagola, Neurologist Postdoctoral Researcher at University Hospital Vall d'Hebron, Barcelona, Spain said a key advantage of using ePatch and the AI analytics platform is in its user-friendly interface and high-quality, 14-day continuous recording capabilities.
"Applied as a chest patch in just a few minutes, it seamlessly integrates an analysis program, facilitating swift examination of recordings,” Dr. Pagola told the press. “Thanks to its AI-based analysis assistant, AF events can be classified for rapid review by our team. Patients experience enhanced comfort as they are free from cumbersome cables of the conventional Holter, allowing them to dress, shower, and carry out their daily activities without any hindrance."
ePatch is also being used in pilot projects at major hospitals in Madrid, Barcelona, Bilbao, Alicante, Madrid, Cadiz, and Navarra to show effectiveness in cardiology and neurology. These applications include monitoring for AFib after cardiac ablation or heart valve replacement, as well as studies of the link between magnesium insufficiency and AFib.
“This innovative new service allows clinical teams to conveniently monitor patients as they go about their everyday activities for extended periods of time, collecting the real-life data that helps reveal the patient’s true condition,” said Miquel Barras, Ambulatory Monitoring & Diagnostics Lead for Philips in Spain.
Philips acquired France-based Cardiologs in 2021.